Incyclinide

DB11647InvestigationalSmall molecule

Incyclinide has been used in trials studying the treatment of HIV Infection, AIDS-related Kaposi Sarcoma, Brain and Central Nervous System Tumors, and Unspecified Adult Solid Tumor, Protocol Specific.

Formula / weight: C₁₉H₁₇NO₇ · 371.345 g/mol (avg)
Code names: CMT-3 · COL-3

Resolves to

Compound

UNII21G64WZQ4ICAS15866-90-7ChEMBLCHEMBL2104970PubChem54678924

Structure

InChIKeyZXFCRFYULUUSDW-OWXODZSWSA-NSMILES[H][C@@]12CC3=C(C(O)=CC=C3)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)C[C@]1([H])C2

Targets

P08253MMP2

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Incyclinide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account